Filing Details

Accession Number:
0001593968-19-001642
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-18 17:12:47
Reporting Period:
2019-07-18
Accepted Time:
2019-07-18 17:12:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1671584 Aptevo Therapeutics Inc. APVO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1380185 Fuad El-Hibri 2401 4Th Avenue
Suite 1050
Seattle WA 98121
Board Of Directors No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-07-18 14,404 $0.87 903,061 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The purchase price of $0.8745 is reflective of the weighted average purchase price. The prices for the transactions reported on this line range from $0.86 to $0.89. Mr. El-Hibri undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.